This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

(CNN) — President Donald Trump says he’s pushed the Food and Drug Administration to eliminate barriers to getting therapeutics for coronavirus to patients.

**See the live blog at the bottom of this page for more**

He said a drug currently used as an antimalarial — hydroxychloroquine — would be made available almost immediately to treat coronavirus.

“It’s been around for a long time so we know if things don’t go as planned it’s not going to kill anybody,” Trump told reporters at the White House.

“We have to remove every barrier or a lot of barriers that were unnecessary and they’ve done that to get the rapid deployment of safe, effective treatments and we think we have some good answers,” Trump said.

FDA Commissioner Stephen Hahn carefully tempered the President’s remarks regarding his team’s work to develop treatments for coronavirus.

“The FDA is committed to continuing to provide regulatory flexibility and guidance, but let me make one thing clear: the FDA’s responsibility to the American people is to ensure that products are safe and effective,” he said.

He said the FDA is expanding its work regarding potential therapeutic options.

“We need to make sure that this sea of new treatments — we’ll get the right drug to the right patient at the right dosage at the right time,” he said, explaining that the right drug may be available but it may not be in the right dosage, “and that may do more harm than good.”

Part of that, Hahn said, is exploring drugs that are “already approved for other indications,” noting the President’s remarks on chloroquine.

“That’s a drug that the President has directed us to take a closer look at as to whether an expanded use approach to that could be done and to actually see if that benefits patients. And again, we want to do that in the setting of a clinical trial, a large, pragmatic clinical trial to actually gather that information,” he said.

He also explained the process of convalescent plasma, which has to do with isolating blood from those who have survived the coronavirus and have the right immunoglobulins. A concentration of that could treat people infected with the virus.

As for a timeline, Hahn said, “over the next couple of weeks, we’ll have more information that we’re really pushing hard to try to accelerate… and that will be a bridge to other therapies that will take us three to six months to develop. And this is a continuous process — there is no beginning and end.”

He also said there is a vaccine trial currently being performed that is expected to take “12 months.”

Early evidence from human cells suggests that chloroquine — which is used to treat malaria and autoimmune diseases — may have some activity against the novel coronavirus. Doctors in China, the US and other countries have used the drug experimentally in Covid-19 patients, but there is not yet sufficient clinical evidence that it’s effective in humans.

The drug, generally considered to be safe for most patients, can have side effects including seizures, nausea, vomiting, deafness, vision changes and low blood pressure.

When asked about chloroquine last month, Dr. Janet Diaz of the World Health Organization said “there is no proof that that is an effective treatment at this time. We recommend that therapeutics be tested under ethically approved clinical trials to show efficacy and safety.”

At the time, she said the drugs that were being prioritized by WHO’s research and development efforts were antivirals, a separate type of drug that includes remdesivir, which is also the focus of clinical trials in China and the US.


  • President Trump says Omar Fakhoury, 57, of Dover, New Hampshire, who had been jailed in Lebanon, has been released. Lebanese officials claimed he was responsible for the killings and abuse of prisoners in Lebanon as part of an Israeli-backed militia two decades ago.
  • Trump: Clinical trials are underway to fight against the virus.
  • Trump: Also approved “compassionate use” for some.
  • Trump: A drug called Chloroquine — a common malaria drug and also a drug used for strong arthritis, it’s been around for a long time. It’s shown very encouraging early results. We’re going to be able to make that drug available almost immediately. FDA has approved this. They took the process down from many months to immediate. It will be available by prescription…”There is tremendous promise based on the results…and other tests there is tremendous promise.” Individual states, doctors will handle the prescriptions.
  • Trump: Studying will also be done as it’s given out to large groups of people.
  • There are also other promising therapies that could soon be approved by the FDA.
  • FDA Commissioner Stephen Hahn: “I have great hope of how we’re going to come out of this situation.”
  • Hahn: FDA approves compassionate use, so if there’s an experimental drug potentially available, a doctor could ask that the drug be made available for a patient.
  • Hahn: We’re looking at drugs already approved for other diseases.
  • Hahn: There is also a vaccine trial being performed, it is in phase 1.
  • VP Mike Pence: Emphasized that those who don’t have symptoms don’t need tests.
  • Pence: We’ve identified tens of thousands of ventilators that can be converted to help treat those with coronavirus.
  • Dr. Deborah Birx: There are dramatic increases in the number of cases is because of increased ability to test and reduction of the backlog of tests.
  • Birx: Still over 50 percent of the cases come from three states, so testing is prioritized for those states.
  • Surgeon General Jerome Adams: Many are home practicing the guidelines, but everyone could consider donating blood. One donation can save up to three lives.
  • Trump begins Q&A
  • Hahn: There are drugs in the pipeline.
  • Pence: There will be a dramatic increase in production of medical masks
  • Trump: Carnival Cruise line will make ships available for medical use if needed.
  • Hahn: Remdesivir is currently in clinical trials here and around the world. Also available through compassionate use for COVID-19 patients.